baseline morbidity in 2,990 adult african volunteers recruited to characterize laboratory reference intervals for future hiv vaccine clinical trials基线发病率在2990年成人非洲志愿者招募u201d来形容实验室参考区间未来艾滋病疫苗临床试验.pdfVIP

Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials 1 2 3 4 5 4 Wendy Stevens , Anatoli Kamali , Etienne Karita , Omu Anzala , Eduard J. Sanders , Walter Jaoko , 2 6 7 8 8 4 Pontiano Kaleebu , Joseph Mulenga , Len Dally , Pat Fast , Jill Gilmour , Bashir Farah , Josephine 9 2 6 8 8 8 Birungi , Peter Hughes , Olivier Manigart , Gwynn Stevens , Sarah Yates , Helen Thomson , Andrea von 8 8 8 10 11 Lieven , Marietta Krebs , Matt A. Price *, Lisa Stoll-Johnson , Nzeera Ketter 1 University of Witwatersrand and Contract Laboratory Services (CLS), Johannesburg, South Africa, 2 Medical Research Council (MRC), Uganda Virus Research Institute (UVRI) Unit on AIDS, Entebbe and Masaka, Uganda, 3 Projet San Francisco (PSF), Kigali, Rwanda, 4 Kenya AIDS Vaccine Initiative (KAVI), Kenyatta National Hospital and Kangemi, Nairobi, Kenya, 5 Centre for Geographic Medicine Research-Coast (CGMRC), Kenya Medical Research Institute (KEMRI), Kilifi, Kenya, 6 Zambia Emory HIV Research Project (ZEHRP), Lusaka, Zambia, 7 The EMMES Corporation, Washington, D.C. United States of America, 8 International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America, 9 Uganda Virus Research Institute (UVRI) / International AIDS Vaccine Initiative (IAVI) HIV Vaccine Program, Entebbe, Uganda,